MedPath

A Retrospective Molecular Epidemiology Study in Singapore Patients With Advanced Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation Status

Conditions
NSCLC
Registration Number
NCT01100827
Lead Sponsor
National University Hospital, Singapore
Brief Summary

To determine EGFR mutation status in patients with advanced stage adenocarcinoma NSCLC.

To determine the association between EGFR mutation status and demographic data in advanced stage adenocarcinoma NSCLC patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Nil

Exclusion Criteria

Nil

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National University Hospital Singapore

🇸🇬

Singapore, Singapore

National University Hospital Singapore
🇸🇬Singapore, Singapore
Ross Andrew Soo, MBBS
Contact
65 6772 4624
ross_soo@nuhs.edu.sg
Ross Soo, MBBS
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.